NEWSROOM

NASDAQ

Blackboxstocks, Inc. and Evtec Aluminium Limited Mutually Agree to Terminate Share Exchange Agreement

Blackboxstocks, Inc. and Evtec Aluminium Limited Mutually Agree to Terminate Share Exchange Agreement

Jan 17, 2025

Blackbox is actively pursuing other strategic merger options to enhance stockholder value DALLAS, Jan. 17, 2025 - PRISM MediaWire - Blackboxstocks Inc. (NASDAQ: BLBX), (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders, announced today that on January 13, 2025 the Company and Evtec Aluminium Limited (“Evtec”) mutually agreed to terminate the Share Exchange Agreement executed on December...

SKYX Announces that it Will Begin Supplying its Products to 140 Commercial Units in January 2025

SKYX Announces that it Will Begin Supplying its Products to 140 Commercial Units in January 2025

Jan 15, 2025

As SKYX Continues to Grow its Market Penetration, it is Expected to Supply Developer Jeremiah Baron Companies Products to a Total of 1000 Mixed-Use Residential and Commercial Units The Products that are Expected to be Supplied to the Mixed-Use Project will include Ceiling Outlet Receptacles, Smart Plug & Play Platform Products including Lighting, Ceiling Fans, Recessed Lights, EXIT Signs, Emergency Lights, Down Lights, and Indoor and Outdoor Wall Lights MIAMI, FL, January 15, 2025 -...

LuxUrban Issues Corporate update and 2025 Revenue Guidance of $62–$67 million

LuxUrban Issues Corporate update and 2025 Revenue Guidance of $62–$67 million

Jan 15, 2025

Streamlined Operations and NYC Focus Set the Stage for 2025 Growth RevPAR Gains and Optimized Portfolio Highlight Operational Momentum MIAMI, Jan. 15, 2025 - PRISM MediaWire - LuxUrban Hotels Inc. (Nasdaq: LUXH), a hospitality company that leases entire hotels on a long-term basis, manages these hotels, and rents out rooms to guests in the properties it leases, today provided a comprehensive corporate update, highlighting recent business achievements and sharing its 2025 revenue guidance and...

BranchOut Food Projects $9 Million in H1 2025 Revenue, Highlighted by $4 Million from Nation’s Largest Warehouse Club

BranchOut Food Projects $9 Million in H1 2025 Revenue, Highlighted by $4 Million from Nation’s Largest Warehouse Club

Jan 15, 2025

Breakthrough Multi-Product, Multi-Region Expansion: Nation’s Largest Warehouse Club Expands Multiple Products Across Four Regions for Transformational Growth Key Highlights: H1 Revenue Surge: Projecting $9M in total revenue, up 218% from the prior year, with strong momentum expected throughout 2025. Nation’s Largest Warehouse Club: Expands BranchOut’s product count and regional footprint across four major markets, driving $4M in H1 sales. Peru Facility Fully Operational: BranchOut celebrates...

LuxUrban Issues Corporate update and 2025 Revenue Guidance of $62–$67 million

Lux Urban Hotels Embraces the Future with Digital Currency–Powered Guest Experiences

Jan 14, 2025

Guests staying at Lux Urban Hotels will soon have the option to pay for their stays using a variety of blockchain-based digital currencies, offering a seamless and decentralized payment experience MIAMI, Jan. 14, 2025 - PRISM MediaWire - LuxUrban Hotels Inc. (Nasdaq: LUXH) a premier name in contemporary urban hospitality, is proud to announce an innovative partnership to enable digital currency payments to all nine properties in the Company’s portfolio. By integrating blockchain-based payment...

Sono-Tek Reports Third Quarter and Nine Months Fiscal 2025 Financial Results

Sono-Tek Reports Third Quarter and Nine Months Fiscal 2025 Financial Results

Jan 13, 2025

Reports Third Consecutive Quarter of Revenue above $5 million First Nine Months Revenue Growth of 3% YOY Backlog Remains Strong at $10.6 Million Provides Guidance for Revenue of over $20 million and Continued Profitability for Fiscal Year 2025 MILTON, N.Y., January 13, 2025 - PRISM MediaWire - Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for the third quarter and nine months of fiscal year 2025,...

Quantum Computing Era is Here and Growing: The Dawn of Practical Artificial Intelligence (AI) and Cybersecurity Applications

Quantum Computing Era is Here and Growing: The Dawn of Practical Artificial Intelligence (AI) and Cybersecurity Applications

Jan 8, 2025

Hauppauge, NY, January 8, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today issued a technical and business opinion written by the company’s CEO/CTO Mr. Fawad Maqbool, which is...

Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco

Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco

Jan 8, 2025

Company to present at 3:00 p.m. PT on Tuesday, January 14, at the Hilton San Francisco Union Square New York, NY, January 8, 2025 - PRISM MediaWire - Klotho Neurosciences, Inc. (NASDAQ: KLTO), a specialty biotechnology company focused on developing cell and gene therapies for amyotrophic lateral sclerosis (ALS), Alzheimer’s, and Parkinson’s disease, announces that it will present at Biotech Showcase 2025, an event expected to include over 3,200 healthcare professionals with more than 1,200...

Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

Jan 8, 2025

Dr. Billings is a renowned diagnostics specialist with a history of commercializing novel assays in precision medicine Will provide key regulatory and reimbursement support Will assist business development efforts and strategic partnerships Irvine, Calif., Jan. 8, 2025 - PRISM MediaWire - Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, announces the appointment of Dr. Paul Billings as the company’s Consulting Chief Medical Officer. In this part-time role, he will support a...

PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials

PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials

Jan 7, 2025

Published Before-and-After Photos Highlight Dramatic Improvements in Netherton Syndrome Patient Treated with QRX003 New York, January 07, 2024 -PRISM MediaWire - PRISM MarketView has released an exclusive interview with Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) CEO Dr. Michael Myers, who shares the company’s notable interim data in its ongoing Netherton Syndrome clinical trials. Quoin, a clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, is addressing unmet...

EzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion

EzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion

Jan 7, 2025

Following the Closing of its 2024 Transactions, EzFill is Now Operating in Miami, West Palm Beach, Orlando, Tampa, Jacksonville, Los Angeles, San Francisco, Nashville, Detroit, Dallas, Houston, Austin, San Antonio, and Phoenix MIAMI, January 07, 2025 – EzFill Holdings, Inc. (NASDAQ: EZFL), a leading mobile fueling company, today announced the completion of its purchase of a fleet of trucks from Shell Retail and Convenience Operations LLC (“Shell”), a wholly owned subsidiary of Shell Oil...

Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

Oncocyte Expands Market Opportunity for VitaGraft™ Kidney

Jan 6, 2025

Medicare coverage expanded following study showing that monitoring with Oncocyte’s assay significantly reduces time to rejection diagnosis in patients with newly developed donor-specific antibodies (DSA) MolDX confirms eligibility for billing under current Local Coverage Determination (LCD) and Z-Code Up to 20% of patients will have detectable DSA within the first five years post kidney transplant, representing greater than 10,000 patients per year in the US.1 From time of onset of dnDSA, 24%...

Quantum Computing Era is Here and Growing: The Dawn of Practical Artificial Intelligence (AI) and Cybersecurity Applications

AmpliTech Group Announces Receipt of Notice of Allowance for Another Patent For Its LNA Technology

Jan 6, 2025

Hauppauge, NY, January 6, 2025 – PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued another Notice...

AmpliTech Group Releases Letter To Shareholders

AmpliTech Group Releases Letter To Shareholders

Dec 31, 2024

Hauppauge, NY, December 31, 2024 – PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced the release of a Letter to Shareholders from its CEO/CTO Mr. Fawad Maqbool. Dear Shareholders...

AmpliTech Group Releases Letter To Shareholders

AmpliTech Group Announces Pricing of $10.0 Million Registered Direct Offering

Dec 30, 2024

HAUPPAUGE, N.Y., Dec. 30, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW) (the “Company”), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced that it has entered into one or more securities purchase agreements with certain...

AmpliTech Group Announces Pricing of $5.8 Million Registered Direct Offering

AmpliTech Group Announces Pricing of $5.8 Million Registered Direct Offering

Dec 26, 2024

HAUPPAUGE, N.Y., December 26, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW) (the “Company”), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced that it has entered into one or more securities purchase agreements with...

EzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion

EzFill Holdings, Inc. Finalizes Letter of Understanding for Purchase of 78 Trucks from Shell

Dec 19, 2024

EzFill to Utilize New Trucks to Begin Servicing Fleet of Large Retailer and Other Customers in Texas and Arizona Miami, FL, December 19, 2024 - PRISM MediaWire - EzFill Holdings, Inc. (NASDAQ: EZFL), a leading mobile fueling company, is pleased to announce the execution of a term sheet with Shell Retail and Convenience Operations LLC (“Shell”), a wholly owned subsidiary of Shell Oil Products US. This agreement facilitates the acquisition of 78 trucks from Shell’s fleet and enables EzFill to...

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis

Dec 19, 2024

Cardiol Therapeutics President and CEO, David Elsley NEW YORK, December 18, 2024 - PRISM MarketView announces the release of an informative interview with Cardiol Therapeutics President and CEO, David Elsley, who discusses the company’s lead oral drug, CardiolRx™, which is entering a late-stage Phase III clinical trial, MAVERIC, for patients with recurrent pericarditis who are at high risk for recurrence. Cardiol Therapeutics is a clinical-stage life sciences company...

SKYX Announces that it Will Begin Supplying its Products to 140 Commercial Units in January 2025

SKYX Collaborates with JIT Electrical Supply, Leading Builder Supplier of Electrical, Lighting and Ceiling Fan Products

Dec 17, 2024

Over the Years JIT has Supplied Over 100,000 U.S. Homes With a Full Range of Quality Lighting, Ceiling Fans and Electrical Products SKYX will provide JIT a full assortment of its Advanced and Smart Plug & Play Products Including Lighting, Ceiling Fans, Recessed Lights, EXIT Signs, Emergency Lights, Down Lights, Indoor and Outdoor Wall Lights and Other JIT Expects to Start Supplying SKYX’s Advanced Plug & Play Products Early 2025 MIAMI, FL, December 17, 2024 - PRISM MediaWire - SKYX...

AmpliTech Group Releases Letter To Shareholders

AmpliTech Group Announces Pricing of $3.1 Million Registered Direct Offering

Dec 17, 2024

HAUPPAUGE, N.Y., Dec. 17, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (NASDAQ: AMPG, AMPGW) (the “Company”), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced that it has entered into one or more securities purchase agreements with certain...

PRISM MediaWire – Press Releases Highlights – December 09 to November 13, 2024

Dec 13, 2024

New York, New York, December 13, 2024 - PRISM MediaWire continued to spotlight groundbreaking stories and transformative announcements shaping industries worldwide this week. From innovative product launches and strategic partnerships to impactful social initiatives, our newsroom captured the pulse of global markets and trends. As 2024 draws to a close, these highlights underscore the resilience, creativity, and forward momentum of businesses and organizations driving change. Dive into this...

AmpliTech Group Releases Letter To Shareholders

AmpliTech Group Delivers Prototype High-Frequency Ultra Low Noise Amplifiers For LEO Satellite Constellations To Fortune 50 Satellite Network Provider

Dec 13, 2024

HAUPPAUGE, N.Y., Dec. 13, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, proudly announces the successful delivery of prototype high-frequency Ultra Low Noise Amplifiers (ULNAs) to a...

AmpliTech Group Releases Letter To Shareholders

AmpliTech Group Announces Pricing of $2.2 Million Registered Direct Offering

Dec 11, 2024

HAUPPAUGE, N.Y., December 11, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW) (the “Company”), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced that it has entered into one or more securities purchase agreements with...

AmpliTech Group Releases Letter To Shareholders

AmpliTech Group Powers The Quantum Computing Revolution With Cutting-Edge Low-Noise Cryogenic HEMT Amplifiers

Dec 11, 2024

HAUPPAUGE, N.Y., Dec. 11, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, proudly announces the successful development and deployment of its proprietary low-noise cryogenic High Electron...

EzFill Closes on the Purchase of Yoshi Mobility’s Fuel Division

EzFill Closes on the Purchase of Yoshi Mobility’s Fuel Division

Dec 10, 2024

--Company Adds 26 New Trucks to Growing Fleet-- --Begins Service in Four New States and Five New Markets-- Miami, FL, December 10, 2024 - PRISM MediaWire - EzFill Holdings Inc. (NASDAQ: EZFL), a leading mobile fueling company, has closed on the purchase of the mobile fueling division of Yoshi, Inc., expanding EzFill’s existing business into five new markets within four states. The transaction closed on Monday, December 2, 2024, and as a result EzFill has officially commenced operations in four...

Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings

Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings

Dec 9, 2024

January 13-16, 2025, San Francisco, CA IRVINE, Calif., December 9, 2024 - PRISM MediaWire - Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend “J.P. Morgan Week,” coinciding with the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, from January 13 - 16, 2025. During this period, Oncocyte will host one-on-one meetings with interested investors....

Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco

Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences’ Scientific Advisory Board

Dec 9, 2024

Klotho Neurosciences, Inc. continues to strengthen its advisory teams with recent new additions of Neuroscience and Big Pharma leaders to Scientific Advisory Board and Board of Directors New York, NY, December 9, 2024 - PRISM MediaWire - Klotho Neurosciences, Inc. (NASDAQ: KLTO), a specialty biotechnology company focused on developing cell and gene therapies for amyotrophic lateral sclerosis (ALS), Alzheimer’s and Parkinson’s disease is proud to announce the appointment of Dr. Merit Cudkowicz,...

SKYX to Conduct a Company Presentation at Benchmark Conference on December 11, 2024, at 3:30pm

Dec 9, 2024

Rani Kohen, Founder, and Lenny Sokolow, Co-CEO of SKYX, to Present at 3:30 PM ET on December 11, 2024, and Engage in Investor Meetings Throughout the Conference at the New York Athletic Club MIAMI, December 9, 2024 - PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and over 60 lighting and home décor websites with a mission to make homes and...

BranchOut Food Inc. Signs LOI and receives $250K PO from Leading Ingredient Distributor, Definitive Agreement Targeting $5-6M in 2025 Ingredient Sales

BranchOut Food Inc. Signs LOI and receives $250K PO from Leading Ingredient Distributor, Definitive Agreement Targeting $5-6M in 2025 Ingredient Sales

Dec 6, 2024

Projecting $4.0M in net revenue for Q1 2025—up 170% from the prior year—and expects to achieve positive cash flow in the same quarter Key Highlights: Signed LOI with leading ingredient distributor, establishing immediate sales volume in the ingredient channel. Received an initial $250,000 purchase order alongside the LOI. Anticipating completing a Definitive Agreement in January with a minimum commitment of $5M in sales for 2025. New Peru factory’s three production lines are now fully...

Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings

Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study

Dec 6, 2024

IRVINE, Calif., Dec. 04, 2024 - PRISM MediaWire - Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, today announced the publication of favorable data regarding its DetermaCNI™ assay. In a paper recently published in the journal Acta Neuropathologica Communications, DetermaCNI showed promise as a liquid biopsy method for diagnosing and profiling central nervous system tumors by measuring somatic copy number aberrations (SCNAs) in cerebrospinal fluid. For context, copy number...